FENOFIBRATE
Generic: FENOFIBRATE
Westminster PharmaceuticalsManufacturer
ORALRoute
FENOFIBRATEActive Substance
2017-12-19Original Approval
FENOFIBRATE is FDA application ANDA207803, sponsored by BOSTAL. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2025-03-13
Fenofibrate Capsules 67 mg, USP, 100-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, PithampurCGMP Deviations
Class II2021-03-15
FENOFIBRATE CAPSULES, UPS 67MG 100 CAPSULES NDC/UPC 27241-118-04; RX; CAPSULESCGMP Deviations: Intermittent exposure to temperature excursion during storage.
Class II2026-05-28
Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma Limited, India, Marketed by: AjaCGMP Deviations
Class III2018-09-12
Fenofibrate Tablets, USP 145 mg, 90-count bottles, Rx only, Manufactured for: Camber Pharmaceuticals, Inc. Piscataway, NPresence of Foreign Tablet/Capsule: A foreign identified as Valacyclovir tablet 500 mg was co-mingle
Top Reported Reactions
1
FATIGUE
2,190 reports
2
DIARRHOEA
2,128 reports
3
NAUSEA
2,057 reports
4
DRUG INEFFECTIVE
1,816 reports
5
HEADACHE
1,575 reports
6
DYSPNOEA
1,549 reports
7
OFF LABEL USE
1,414 reports
8
DIZZINESS
1,397 reports
9
PAIN
1,388 reports
10
FALL
1,372 reports